Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07127484 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hemoadsorption for Severe Ischemic Stroke

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion date: Jan 31, 2027 to Feb 28, 2027
    • Collaborators: 9 to 8
    v4
  2. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Sep 30, 2026 to Jan 31, 2027
    • Study completion date: Dec 30, 2026 to Feb 28, 2027
    • Start date changed from estimate of Dec 30, 2025 to Jan 5, 2026
    • Collaborators: 10 to 9
  3. Notable Start date: Sep 1, 2025 to Dec 30, 2025
    • Eligibility criteria expanded, about 30 words
    • Collaborators: 9 to 10
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, randomized-controlled, open-label, blinded endpoint clinical trial that aims to evaluate the efficacy and safety of hemoadsorption for severe ischemic stroke
Trial Details
NCT Number NCT07127484
Lead Sponsor First Affiliated Hospital of Wannan Medical College
Collaborators: Anqing Municipal Hospital, Beijing Tiantan Hospital, Baotou Central Hospital, The NO.1 People's Hospital of Shizuishan, Fuyang people's hospital, Second People's Hospital of Hefei City, The First Affiliated Hospital of Zhengzhou University, THE SECOND PEOPLE'S HOSPITAL, WUHU
Conditions
(from sponsor)
Ischemic Stroke, Hemoadsorption
Related terms Ischemic Stroke
Enrollment 116 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov